Proceedings of 26th Annual Technological Advances in Science, Medicine and Engineering Conference 2022

Determine the Effects of a 3'-Hydroxypterostilbene on Dopaminergic and Hippocampal Neurons
surekha kadannagari, Keyi liu, Suhrud Pathak, Sindhu Ramesh, Jack Deruiter, Satyanarayana Pondugula Pondugula, Timothy Moore, Muhammed Majeed, Nagabhushanam Kalyanam, Muralikrishnan Dhanasekaran
Abstract

Pterostilbene (dimethyl ether analog of resveratrol)is metabolically stable and displayed substantially superior pharmacological activities as compared to the well-established natural bioactive, resveratrol. 3'-Hydroxypterostilbene (a natural pterostilbene analog and a metabolite) is a known apoptosis activatorand autophagy inducer.  3'-Hydroxypterostilbene inhibits Sirtuin, PI3K/Akt/mTOR/p70S6K, and p38MAPK pathways and activates the ERK1/2, JNK1/2 MAPK pathways.  The current literature reveals it to possess antimicrobial (anti-fungal), anti-obesity, and anti-cancer (skin, leukemia, and colon) activities. At present, there are no reports on the actions of 3'-Hydroxypterostilbene on the central nervous system. Consequently, there is a void in the neuropharmacological effect of 3'-Hydroxypterostilbene.  Therefore, this research study investigated the effect of 3'-Hydroxypterostilbene on the dopaminergic and hippocampal neurons.  Additionally, in-silico analyses were performed to validate its neuro-pharmacodynamic effects.  3'-Hydroxypterostilbene was incubated with different doses at two different time points to establish the effect on dopaminergic and hippocampal neuronal viability.  Endogenous neurotoxin, hydrogen peroxide was used as a positive control.  Statistical analysis was performed using Prism-V software.  The in-silico and in vitro studies established the pharmacokinetic profile and the effect of 3'-Hydroxypterostilbene on dopaminergic and hippocampal neuronal viability. 


Last modified: 2022-08-20
Building: TASME Center
Room: Medicine Hall
Date: August 27, 2022 - 10:45 AM – 11:05 AM

<< Back to Proceedings